
    
      All patients will receive FOLFOX-A every 14 days of each cycle (1 cycle = 28 days).
      Nab-paclitaxel will be given at a dose of 150 mg/m^2 IV over 30 minutes, followed by
      oxaliplatin IV 85 mg/m^2 and leucovorin IV 400 mg/m^2 over 2 hours, and 5-FU as a continuous
      IV infusion over Day 1 and Day 2 (for a total dose of 2400mg/m^2 over 46-48 hours.).
      Radiographic assessment will be performed at baseline and every 8 weeks to evaluate response
      to treatment by RECIST Version 1.1 guidelines. Patients may continue to receive treatment
      until disease progression or unacceptable toxicity.
    
  